EMFAT
TGTX icon

Emerald Mutual Fund Advisers Trust’s TG Therapeutics TGTX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-277,154
Closed -$13.4M – 239
2021
Q1 		$13.4M Buy
+277,154
New +$13.3M 0.44% 93

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TGTX Position: Q2 2021 in Review

Emerald Mutual Fund Advisers Trust sold out of TG Therapeutics (TGTX) in Q2 2021, closing a stake of 277,154 shares — an estimated $13.4M sold.

Emerald Mutual Fund Advisers Trust first reported a position in TGTX in Q1 2021 and held it in 1 quarter. The position peaked at $13.4M in Q1 2021. 237 funds tracked by Wall St. Rank hold TGTX as of Q2 2021.

  • Emerald Mutual Fund Advisers Trust reported no remaining TG Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 277,154 TG Therapeutics shares in Q2 2021, an estimated $13.4M.
  • Emerald Mutual Fund Advisers Trust first reported a position in TG Therapeutics in Q1 2021 and held it in 1 quarter.
  • Emerald Mutual Fund Advisers Trust's TG Therapeutics position peaked at $13.4M in Q1 2021.
  • 237 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2021.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2021, filed 29 Jul 2021.